Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 28;27(9):2803.
doi: 10.3390/molecules27092803.

Antioxidant Activity of Ruthenium Cyclopentadienyl Complexes Bearing Succinimidato and Phthalimidato Ligands

Affiliations

Antioxidant Activity of Ruthenium Cyclopentadienyl Complexes Bearing Succinimidato and Phthalimidato Ligands

Michał Juszczak et al. Molecules. .

Abstract

In these studies, we investigated the antioxidant activity of three ruthenium cyclopentadienyl complexes bearing different imidato ligands: (η5-cyclopentadienyl)Ru(CO)2-N-methoxysuccinimidato (1), (η5-cyclopentadienyl)Ru(CO)2-N-ethoxysuccinimidato (2), and (η5-cyclopentadienyl)Ru(CO)2-N-phthalimidato (3). We studied the effects of ruthenium complexes 1-3 at a low concentration of 50 µM on the viability and the cell cycle of peripheral blood mononuclear cells (PBMCs) and HL-60 leukemic cells exposed to oxidative stress induced by hydrogen peroxide (H2O2). Moreover, we examined the influence of these complexes on DNA oxidative damage, the level of reactive oxygen species (ROS), and superoxide dismutase (SOD) activity. We have observed that ruthenium complexes 1-3 increase the viability of both normal and cancer cells decreased by H2O2 and also alter the HL-60 cell cycle arrested by H2O2 in the sub-G1 phase. In addition, we have shown that ruthenium complexes reduce the levels of ROS and oxidative DNA damage in both cell types. They also restore SOD activity reduced by H2O2. Our results indicate that ruthenium complexes 1-3 bearing succinimidato and phthalimidato ligands have antioxidant activity without cytotoxic effect at low concentrations. For this reason, the ruthenium complexes studied by us should be considered interesting molecules with clinical potential that require further detailed research.

Keywords: DNA oxidative damage; ROS; SOD activity; cell cycle; hydrogen peroxide; phthalimide; ruthenium metallocarbonyl complexes; succinimide.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
The structures of the ruthenium complexes 13.
Figure 2
Figure 2
Effect of ruthenium complexes 13 at 50 µM on the viability of PBMCs and HL-60 cells incubated with H2O2. The viability for individual samples was calculated relative to negative control (untreated cells) ± SD. Cell viability in the control was taken as 100%, n = 6, * p < 0.05, *** p < 0.001 vs. negative control, ## p < 0.01, ### p < 0.001 vs. H2O2.
Figure 3
Figure 3
Effect of ruthenium complexes 13 at 50 μM on H2O2-induced DNA damage in PBMCs and HL-60. The figures show mean results ± SEM, n = 100; *** p < 0.001 vs. negative control; # p < 0.05, ### p < 0.001 vs. H2O2.
Figure 4
Figure 4
Changes in reactive oxygen species (ROS) level in PBMCs and HL-60 cells pre-incubated with ruthenium complexes 13 at 50 μM for 24 h at 37 °C and then incubated with 1 mM or 5 mM H2O2 at 37 °C. Each value represents the mean ± SD, n = 6; * p < 0.05, ** p < 0.01, *** p < 0.001 vs. negative control; ## p < 0.01, ### p < 0.001 vs. H2O2.
Figure 5
Figure 5
Superoxide dismutase activity in PBMCs and HL-60 cells pre-incubated for 24 h at 37 °C with ruthenium complexes 13 at 50 µM and then incubated with H2O2 at 0.25 mM in the case of PBMCs and 0.1 mM in the case of HL-60 cells. The figure shows the mean results ± SD, n = 3; * p < 0.05, and *** p < 0.001 vs. negative control; ### p < 0.001 vs. H2O2. Data were normalized to the negative control, which was assigned as 100% of the SOD activity.

Similar articles

Cited by

References

    1. Singh A., Barman P. Recent Advances in Schiff Base Ruthenium Metal Complexes: Synthesis and Applications. Top. Curr. Chem. 2021;379:29. doi: 10.1007/s41061-021-00342-w. - DOI - PubMed
    1. Kacsir I., Sipos A., Ujlaki G., Buglyó P., Somsák L., Bai P., Bokor É. Ruthenium Half-Sandwich Type Complexes with Bidentate Monosaccharide Ligands Show Antineoplastic Activity in Ovarian Cancer Cell Models through Reactive Oxygen Species Production. Int. J. Mol. Sci. 2021;22:10454. doi: 10.3390/ijms221910454. - DOI - PMC - PubMed
    1. Mahmud K.M., Niloy M.S., Shakil M.S., Islam M.A. Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment. Pharmaceutics. 2021;13:1295. doi: 10.3390/pharmaceutics13081295. - DOI - PMC - PubMed
    1. Sun Q., Li Y., Shi H., Wang Y., Zhang J., Zhang Q. Ruthenium Complexes as Promising Candidates against Lung Cancer. Molecules. 2021;26:4389. doi: 10.3390/molecules26154389. - DOI - PMC - PubMed
    1. Juszczak M., Kluska M., Kosińska A., Palusiak M., Rybarczyk-Pirek A.J., Wzgarda-Raj K., Rudolf B., Woźniak K. Cytotoxicity of piano-stool ruthenium cyclopentadienyl complexes bearing different imidato ligands. Appl. Organomet. Chem. 2022;36:e6595. doi: 10.1002/aoc.6595. - DOI

MeSH terms

LinkOut - more resources